Karin Leandersson - Cantargia Director
| CANTA Stock | SEK 3.42 0.18 5.56% |
Director
Ms. Karin Leandersson has served as Member of the Board of Directors of Cantargia AB since May 25, 2016. She is associate professor in tumor immunology at the medical faculty at the University of Lund. Leandersson has a wide experience in cancer research in the fields of tumor immunology and tumor inflammation in solid tumors, mainly in breast cancer. Leandersson has authored around 30 scientific publications in international journals. since 2016.
| Age | 43 |
| Tenure | 8 years |
| Phone | 46 4 62 75 62 60 |
| Web | https://www.cantargia.com |
Cantargia Management Efficiency
The company has return on total asset (ROA) of (0.3963) % which means that it has lost $0.3963 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6913) %, meaning that it generated substantial loss on money invested by shareholders. Cantargia's management efficiency ratios could be used to measure how well Cantargia manages its routine affairs as well as how well it operates its assets and liabilities. Cantargia AB , a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. Cantargia AB was founded in 2010 and is based in Lund, Sweden. Cantargia operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people. Cantargia AB (CANTA) is traded on Stockholm Exchange in Sweden and employs 27 people.Management Performance
| Return On Equity | -0.69 | |||
| Return On Asset | -0.4 |
Cantargia AB Leadership Team
Elected by the shareholders, the Cantargia's board of directors comprises two types of representatives: Cantargia inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cantargia. The board's role is to monitor Cantargia's management team and ensure that shareholders' interests are well served. Cantargia's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cantargia's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karin Leandersson, Director | ||
| Magnus Persson, Chairman of the Board | ||
| Dominique Tersago, Chief Officer | ||
| Liselotte Larsson, Vice President - Operations | ||
| David Liberg, Vice President Cancer Research | ||
| Kjell Sjstrm, Founder | ||
| Johanna Christensen, Financial Controller | ||
| Goran Forsberg, Chief Executive Officer | ||
| Nina Valkama, Exec Fin | ||
| Bengt Jondell, Chief Financial Officer | ||
| Adnan Deronic, IP Mang | ||
| Lars Thorsson, Vice President Clinical Development | ||
| Ignacio GarciaRibas, Chief Medical Officer | ||
| Susanne Lagerlund, Vice President - Regulatory Affairs | ||
| Thoas MD, Founder Director | ||
| Marcuss, Founder Advisor | ||
| Anders MartinLof, Director | ||
| Thoas Fioretos, Director | ||
| Patricia Delaite, Director | ||
| Claus Andersson, Director | ||
| Peter Madsen, Vice President - CMC |
Cantargia Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cantargia a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.69 | |||
| Return On Asset | -0.4 | |||
| Current Valuation | 34.5 M | |||
| Shares Outstanding | 166.99 M | |||
| Shares Owned By Insiders | 9.10 % | |||
| Shares Owned By Institutions | 33.60 % | |||
| Price To Earning | 2.12 X | |||
| Price To Book | 1.11 X | |||
| EBITDA | (363.06 M) | |||
| Net Income | (370.27 M) |
Pair Trading with Cantargia
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cantargia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cantargia will appreciate offsetting losses from the drop in the long position's value.Moving against Cantargia Stock
| 0.55 | BIOA-B | BioArctic AB | PairCorr |
| 0.48 | LUND-B | L E Lundbergfretagen | PairCorr |
The ability to find closely correlated positions to Cantargia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cantargia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cantargia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cantargia AB to buy it.
The correlation of Cantargia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cantargia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cantargia AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cantargia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cantargia AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Cantargia AB information on this page should be used as a complementary analysis to other Cantargia's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Cantargia Stock analysis
When running Cantargia's price analysis, check to measure Cantargia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cantargia is operating at the current time. Most of Cantargia's value examination focuses on studying past and present price action to predict the probability of Cantargia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cantargia's price. Additionally, you may evaluate how the addition of Cantargia to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |